Intensive Glucose Control in Type 2 Diabetes Increases Mortality Risk

by Anjali Aryamvally on  November 16, 2017 at 1:37 PM Diabetes News
RSS Email Print This Page Comment bookmark
Font : A-A+

Intensive glucose control, a common approach to achieve low blood sugar targets in type 2 diabetes can increase the risk of mortality, reports a study by Cardiff University.
Intensive Glucose Control in Type 2 Diabetes Increases Mortality Risk
Intensive Glucose Control in Type 2 Diabetes Increases Mortality Risk

Looking at routine data from over 300,000 people in the UK, collected between 2004 and 2015, researchers found that lower levels of glycated haemoglobin--typically regarded as being good diabetes control - were associated with increased mortality risk, compared to moderate levels, especially in conjunction with intensive treatments that could cause hypoglycaemia.

Show Full Article


Professor Craig Currie from Cardiff University's School of Medicine said: "Treatment guidelines generally recommend therapeutic strategies that aim for low levels of glucose control, on the understanding that it reduces risk of macrovascular complications such as coronary artery disease and stroke. Contrary to this belief, our findings show persuasively that there is an association with increased mortality risk and what is considered to be good glucose control, or low HbA1c."

The findings of the study also suggest that neither randomised trials nor observational studies have been able to demonstrate a consistent pattern of association between levels of glucose control and adverse outcome, without any explanation as to why. Thus, the optimal target for glucose control in patients with type 2 diabetes remains uncertain. Furthermore, the pattern of mortality in relation to glucose control differed in relation to differing types of diabetes drugs. Of most concern was an increase in mortality risk in those with 'good control' with type 2 diabetes who were treated with insulin and other glucose lowering drugs that induce hypoglycaemia.

Professor Currie said: "Serious questions remain about the safety of some glucose lowering drugs, with scientific evidence and opposing opinions being largely ignored."



Source: Eurekalert

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

Recommended Reading

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Premium Membership Benefits

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Stay Connected

  • Available on the Android Market
  • Available on the App Store

News Category

News Archive